Capital Asset Advisory Services LLC Gilead Sciences, Inc. Transaction History
Capital Asset Advisory Services LLC
- $2.01 Billion
- Q4 2024
A detailed history of Capital Asset Advisory Services LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Capital Asset Advisory Services LLC holds 4,004 shares of GILD stock, worth $384,504. This represents 0.02% of its overall portfolio holdings.
Number of Shares
4,004
Previous 3,637
10.09%
Holding current value
$384,504
Previous $304,000
21.38%
% of portfolio
0.02%
Previous 0.02%
Shares
29 transactions
Others Institutions Holding GILD
# of Institutions
1,990Shares Held
992MCall Options Held
10.5MPut Options Held
9.85M-
Black Rock Inc. New York, NY121MShares$11.6 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$11.1 Billion0.18% of portfolio
-
Capital World Investors Los Angeles, CA76.5MShares$7.35 Billion1.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.8MShares$5.93 Billion1.12% of portfolio
-
State Street Corp Boston, MA60.2MShares$5.78 Billion0.21% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $120B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...